Episodes
Friday May 20, 2022
Friday May 20, 2022
Unfortunately, many patients with CAD do not receive the influenza vaccine every year. And many patients being discharged from hospital after an acute coronary event don't receive it either. The IAMI (Influenza Vaccination After Myocardial Infarction) study was the first, large, randomized, double-blind, placebo-controlled, multi-center trial to investigate whether influenza vaccination could reduce the rate of cardiovascular events in high-risk adults with CAD.
Guest Authors: Noelle Cordova, PharmD and Laura McAuliffe, PharmD, BCACP, CDCES
Music by Good Talk
Sunday Aug 26, 2018
Sunday Aug 26, 2018
We now have two vaccinations to protect against herpes zoster — a live-attenuated vaccine (Zostavax) and the new recombinant subunit vaccine (Shingrix). While the live-attenuated vaccine has been available for more than a decade and a CDC-recommended vaccine in older adults, only one in three eligible patients have received it. Based on the results of two recently published studies, the new recombinant subunit vaccine appears to provide substantially improved efficacy and duration.
Guest Author: Katherine Montag Schafer, PharmD, BCACP
Music by Good Talk